Published in Hepatitis Weekly, March 22nd, 1999
Patients on renal replacement therapy, hemodialysis (HD), or after kidney transplantation (TX), are known to be at risk of acquiring blood-borne infections (HBV, HCV). GBV-C/Hepatitis G virus (HGV) has been described recently and is considered to cause blood-borne infections.
The aim of this study was to analyze the risk for the medical staff of HD and TX patients to acquire HGV infection ("High Prevalence of Hepatitis G Virus Infections in Dialysis Staff," Nephrol Dial...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly